Psychoactive Drugs in Psychosomatic Medicine

  • J. Ananth


When dealing with a patient who has a chronic or a life-threatening illness, physical illness receives utmost care but psychosomatic aspect very little. Thus, we speak of the “coronary” needing intensive care and the “psychosomatic” needing psychotherapy which in fact is responding to one part of the problem. The patient who suffers from a disease is neither psyche nor soma alone and will be grateful to you if he will derive benefit from a comprehensive therapy. The origin, perpetuation and treatment of psychosomatic illnesses are multifaceted. Focusing on one aspect of the problem to the exclusion of others is definitely not beneficial. I address myself primarily to the usefulness of psychoactive drugs in some of the physical disorders not to imply its exclusive value but to expose its synergestic value with other forms of therapy. In addition, the opposite problem, rather more serious, psychosomatic disorders secondary to psychoactive drug therapy will also be elucidated to impart the feeling that art of using the medication in the total treatment regime and not mere application is important.


Chronic Pain Psychiatric Patient Trigeminal Neuralgia Psychoactive Drug Psychosomatic Medicine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adler, R.H.: Psychotropic agents in the management of chronic pain. J. Human Stress 4; 13–17, 1978.PubMedCrossRefGoogle Scholar
  2. Ananth, J.: Antiasthmatic effects of chrlorpromazine. Canad. Med. Assoc. J. 110; 1131, 1974.PubMedGoogle Scholar
  3. Ananth, J. and Huapaya, L.: Depression associated with hypertension: a review. Psychiat. J. Univ. Ottawa 5; 58–62, 1980.Google Scholar
  4. Bradley, J.J.: Severe localized pain associated with the depressive syndrome. Brit. J. Psychiat. 109; 741–745, 1963.PubMedCrossRefGoogle Scholar
  5. Chevenne, J.: Treatment of pain with a group of phenothiazine amines. La Presse Medicale 68; 2347-, 1960.Google Scholar
  6. Couch, J.R., Zeigler, D.K. and Hassanein, R.: Amitriptyline in the prophylaxis of migraine. Neurology 26; 121–127, 1976.PubMedGoogle Scholar
  7. Crocket, J.A.: Chlorpromazine in asthma, chronic bronchitis and emphysema. Brit. J. Tuberculosis Dis. Chest 50; 221–224, 1956.CrossRefGoogle Scholar
  8. Csatary, L.K.: Cancer and chlorpromazine. Lancet. 2; 338–339, 1972.PubMedCrossRefGoogle Scholar
  9. Dabbs, C.H. and Peirce, E.C.: Causalgiz treated with chlorpromazine hydrochloride. J.A.M.A. 159; 1626–1628, 1955.CrossRefGoogle Scholar
  10. Freyhan, F.A.: Loss of ejaculation during mellaril treatment. Amer. J. Psychiat. 118; 171–172, 1961.PubMedGoogle Scholar
  11. Friedman, A.P.: The migraine syndrome. Bull. N.Y. Acad. Med. 44; 45–62, 1968.PubMedGoogle Scholar
  12. Gardos, G. and Cole, J.O.: Weight reduction in schizophrenics by molindone. Amer. J. Psychiat. 134; 302–304, 1977.PubMedGoogle Scholar
  13. Goldfarb, A.A. and Venutolo, F.: The use of an antidepressant drug in chronically allergic individuals. Ann. Allergy 21; 667676, 1963.Google Scholar
  14. Gomersall, J.D. and Stuart, A.: Amitriplyline in migraine prophylaxis. J. Neurol. Neurosurg. Psychiat. 36; 684–690, 1973.PubMedCrossRefGoogle Scholar
  15. Gordon, R.A. and Campbell, M.: The use of chlorpromazine in intractable pain associated with terminal carcinoma. Canad. Med. Assoc. J. 75; 420–421, 1956.PubMedGoogle Scholar
  16. Greer, S., Morris, T. and Pettingale, K.W.: Psychological response to breast cancer: effect on outcome. Lancet. 2; 785–787, 1979.PubMedCrossRefGoogle Scholar
  17. Guy, R.: An essay on scirrous tumours and cancer. J & A Churchill: London, 1959.Google Scholar
  18. Hart, F.D.: The use of psychotropic drugs in rheumatology. J. Int. Med. Res. 4; 15–19, 1976.PubMedGoogle Scholar
  19. Heller, J.: Another case of inhibition of ejaculation as side effect of mellaril. Amer. J. Psychiat. 118; 173–174, 1961.PubMedGoogle Scholar
  20. Hill, R., Bell, C., Goldberg, H.: Effect of fluphenazine hydrochloride on R3230 A.C. mammary carcinoma and mammary glands of the rat. Cancer Res. 31; 1111–1127, 1971.Google Scholar
  21. Katz, J., Kunofsky, S., Patton, R.E.: Cancer mortality among patients in New York mental hospitals. Cancer 20; 2194–2199, 1967.PubMedCrossRefGoogle Scholar
  22. Kerr, T.A., Schapira, K. and Roth, M.: The relationship between premature death and affective disorder. Brit. J. Psychiat. 115; 1277–1282, 1969.PubMedCrossRefGoogle Scholar
  23. Lance, J.W. and Curran, D.A.: Treatment of chronic tension headache. Lancet 2; 1236–1239, 1964.CrossRefGoogle Scholar
  24. Lasagna, L. and DeKornfeld, T.J.: Methotrimeprazine: a new phenothiazine derivative with analgestic properties. J.A.M.A. 178; 887–888, 1961.PubMedCrossRefGoogle Scholar
  25. Lassman, P.L., Moody, J.F. and Gryspeerdt, G.L.: Central pain due to cerebral ischaemia. folia psychiatrica neurologica, et Neuroschiriargica Needlandica 62; 34–1959.Google Scholar
  26. Lee, R. and Spencer, P.S.J.: Antidepressants and pain: a review of the pharmacological data supporting the use of certain tricyclics in chronic pain. J. Inter. Med. Res. 5; 146–156, 1977.Google Scholar
  27. Lesse, S.: Masked depression–a diagnostic and therapeutic problem. Dis. Nerv. Syst. 29; 169–173, 1968.PubMedGoogle Scholar
  28. Levij, I.S. and Polliak, A.: Inhibitions of chemical carcinogenesis in the hamster cheek pouch by topical chlorpromazine. Nature 228; 1096–1097, 1970.PubMedCrossRefGoogle Scholar
  29. Lindsay, P.G. and Wyckoff, M.: The depression pain syndrome and its response to antidepressants. Psychosomatics 22; 571–577, 1981.PubMedGoogle Scholar
  30. Mahloudji, M.: Prevention of migraine. Brit. Med. J. 1; 182–183, 1969.PubMedCrossRefGoogle Scholar
  31. Mearles, R.A., Mills, J.E., Horvath, T.B., Atkinson, J.M., Pun, L.Q. and Rand, M.J.: Amitriptyline and asthma. Med. J. Aust. 2; 25–28, 1971.Google Scholar
  32. Merskey, H.:• Psychiatric patients with persistent pain. J. Psychosom. Res. 10; 383–387, 1967.PubMedCrossRefGoogle Scholar
  33. Merskey, H. and Hester, R.A.: The treatment of chronic pain with psychotropic drugs. Postgrad. Med. J. 48; 594–598, 1972.PubMedCrossRefGoogle Scholar
  34. Montilla, E., Frederick, W.S. and Cass, L.J.: Analgesic effect of methotrimeprazine and morphine: a clinical comparison. Arch. Int. Med. 111; 725, 1963.CrossRefGoogle Scholar
  35. Panaccio, V.: Trimeprazine: a new phenothiazine derivative for treatment of pruritic dermatoses. Canad. Med. Assoc. J. 80; 885–1959.Google Scholar
  36. Paoli, R., Darcourt, G. and Cossa, P.: Preliminary note on the action of imipramine in painful states. Rev. Neurol. 102; 503–1960.Google Scholar
  37. Paradis, B.: Analgesic and anaesthitic properties of levomepromazine (NO2INAN–7044RP). Canad. Anaesthetists Soc. J. 9; 153–1962.Google Scholar
  38. Pilowsky, I., Chapman, C.R. and Bonica, J.J.: Pain, depression and illness behavior in a pain clinic population. Pain 4; 183191, 1977.Google Scholar
  39. Pisciotta, A.V.: Agronulocytosis induced by certain phenothiazine derivaties. J.A.M.A. 208; 1862–1868, 1969.PubMedCrossRefGoogle Scholar
  40. Pudov, V.I.: Effect of aminazine on metastatic dissemination of Brown-Pearce tumour. Farmikol Toksikol. 34; 454–456, 1971.Google Scholar
  41. Rassidakis, N.C., Kelleporis, M. and Fox, S.: Malignant neoplasma as a cause of death among psychiatric patients. Int. Ment. Health Res. Newsletter 13; 6, 1971. •Google Scholar
  42. Rassidakis, N.C., Kelleporis, M. and Karaiassefidis, K.: Malignant neoplasm as a cause of death among psychiatric patients. Int. Mental Health Res. Newsletter 14; 1–3, 1972.Google Scholar
  43. Robinson, K.C., Zuck, D.: Chlorpromazine in status asthmaticus. Lancet 1; 1349, 1954.CrossRefGoogle Scholar
  44. Sanger, M.D.: Psychosomatic allergy. Psychosomatics 11; 473–476, 1970.PubMedGoogle Scholar
  45. Scott, W.A.M.: The relief of pain with an antidepressant in arthritis. Practioner 202; 802–807, 1969.Google Scholar
  46. Shader, R.I.: Sexual dysfunction associated with thioridazine hydrochloride. J.A.M.A. 188; 1007–1009, 1964.PubMedCrossRefGoogle Scholar
  47. Shader, R.I., Nahun, J.P. and DiMascio A.: Amenorrhea in psycho-tropic drug side effects. (Ed) R.I. Shaker & A. DiMascio, Baltimore, Williams & Wilkins, 1970.Google Scholar
  48. Sigwald, J., Bouttier, D. and Caille, F.: The treatment of herpes and post-herpetic pain. Study of the results obtained with levomepromazine. Therapie 14; 818–1959.Google Scholar
  49. Sigwald, J., Herbert H. and Quetin A.: The treatment of herpes and post-herpetic pain with phenothiazine derivatives. Semaine des hopitaux de Paris 33; 1137–1957.Google Scholar
  50. Singh, G. and Verma, H.C.: Drug treatment of chronic intractable pain in patients referred to a psychiatry clinic. J. Indian Med. Ass. 56; 341–345, 1971.PubMedGoogle Scholar
  51. Singh, H.: Case of inhibition of ejaculation as side effect of mellaril. Amer. J. Psychiat. 117; 1041–1042, 1961.Google Scholar
  52. Snow, H.: Cancer and cancer process. J & A Churchill: London, 1893.Google Scholar
  53. Spear, F.G.: Pain in psychiatric patients. J. Psychosom. Res. 11; 187–193, 1967.PubMedCrossRefGoogle Scholar
  54. Sternbach, R.A., Janowski, D.S., Huey, L.Y.: Effects of altering brain serotonin activity on human chronic pain. In Bonica J.J. (ed): Advances in pain research and therapy. New York. Raven Press. 1976. Vol. 1, pp. 601–606.Google Scholar
  55. Sughihara, H., Ishiara, K. and Noguchi, H.: Clinical experience with amitriptyline (tryptonol) in the treatment of bronchial asthma. Ann. Allergy 23; 422–1965.Google Scholar
  56. Surawicz, F.G., Brightwell, D.R., Weitzel, D.W. and Ekkehard, O.: Cancer, emotions and mental illness: the present state of understanding. Amer. J. Psychiat. 133; 1306–1309, 1976.PubMedGoogle Scholar
  57. Taub, A.: Relief of postherpetic neurolgia with psychotropic drugs. J. Neurosurg. 39; 235–239, 1973.PubMedCrossRefGoogle Scholar
  58. Taubel, D.E.: Mellaril: Ejaculation disorders. Amer. J. Psychiat. 119; 87–1962.Google Scholar
  59. Taylor, D.C.: The components of sickness: diseases, illnesses and predicaments. Lancet 2; 1008–1010, 1979.PubMedCrossRefGoogle Scholar
  60. Tyber, M.A.: Treatment of painful shoulder syndrome with amitriptyline and lithium carbonate. Canad. Med. Assoc. J. 111; 137140, 1974.Google Scholar
  61. Varsamis, J., Zuckhowski, T. and Maini, K.K.: Survival rates of death in geriatric psychiatric patients: a six year follow-up. Canad. Psychiat. Assoc. J. 7; 17–22, 1972.Google Scholar
  62. Von Knorring, L.: The experience of pain in depressed patients. Neuropsychobiology 1; 155–165, 1975.PubMedCrossRefGoogle Scholar
  63. Ward, N.G., Bloom, V.L. and Friedel, R.O.: The effectiveness of tricyclic antidepressants in the treatment of co-existing pain and depression. Pain 7; 331–341, 1979.PubMedCrossRefGoogle Scholar
  64. Watson, C.G. and Schuld, D.: Psychosomatic factors in the etiology of neoplasms. J. Consultative and Clinical Psycholosy 45; 455–464, 1977.CrossRefGoogle Scholar
  65. Webb. H.E. and Larscelles, R.G.: Treatment of facial and head pain associated with depression. Lancet 1; 355–356, 1962.Google Scholar
  66. Whitlock, F.A. and Siskind, M.: Depression and cancer: a followup study. Psychol. Med. 9; 747–752, 1979.PubMedCrossRefGoogle Scholar
  67. Wilson, R.C.D.: Antiasthmatic effect of amitriptyline. Canad. Med. Assoc. J. 111; 212, 1974.PubMedGoogle Scholar
  68. Woodforde, J.M., Dwyer, B., McEwen, B.W.: Treatment of postherpetic neurolgia. Med. J. Australia 2; 869–872, 1965.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • J. Ananth
    • 1
  1. 1.Department of Psychiatry Psychopharmacology UnitUniversity of California, Los Angeles Harbor-U.C.L.A. Medical CenterTorranceUSA

Personalised recommendations